Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome

This publication has 21 references indexed in Scilit:

• Analysis of serial measurements in medical research.
  BMJ, 1990
• LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome
  Gynecological Endocrinology, 1990
• Ovarian response to combined growth hormone-gonadotropin treatment in patients resistant to induction of superovulation
  Gynecological Endocrinology, 1989
• Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
  Journal of Clinical Investigation, 1989
• Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.
  BMJ, 1988
• Pancreatic Beta Cell Function in Polycystic Ovary Syndrome: Its Relationship to Body Weight, Serum Testosterone and Serum Prolactin Levels
  Experimental and Clinical Endocrinology & Diabetes, 1987
• Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
  BMJ, 1986
• The Effect of SMS 201-995, a Long-Acting Somatostatin Analogue, on Anterior Pituitary Function in Healthy Male Volunteers
  Scandinavian Journal of Gastroenterology, 1986
• Inhibition by Somatostatin of LH-RH-Induced LH Release in Normal Menstruating Women
  Gynecologic and Obstetric Investigation, 1986
• REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
  Clinical Endocrinology, 1980